Kurt Huber

83.9k total citations · 10 hit papers
822 papers, 29.9k citations indexed

About

Kurt Huber is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Kurt Huber has authored 822 papers receiving a total of 29.9k indexed citations (citations by other indexed papers that have themselves been cited), including 490 papers in Cardiology and Cardiovascular Medicine, 281 papers in Surgery and 93 papers in Internal Medicine. Recurrent topics in Kurt Huber's work include Acute Myocardial Infarction Research (244 papers), Antiplatelet Therapy and Cardiovascular Diseases (175 papers) and Coronary Interventions and Diagnostics (132 papers). Kurt Huber is often cited by papers focused on Acute Myocardial Infarction Research (244 papers), Antiplatelet Therapy and Cardiovascular Diseases (175 papers) and Coronary Interventions and Diagnostics (132 papers). Kurt Huber collaborates with scholars based in Austria, Germany and United States. Kurt Huber's co-authors include Johann Wojta, Gerald Maurer, Shephal K. Doshi, Vivek Y. Reddy, Saibal Kar, Horst Sievert, Walter S. Speidl, Matthew J. Price, David R. Holmes and Christoph Kaun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Kurt Huber

794 papers receiving 29.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy

2014 1.2k citations Kurt Huber et al. profile →
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

2011 822 citations Kurt Huber et al. profile →
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation

2012 763 citations Héctor Bueno, Kurt Huber et al. profile →
Guidelines on myocardial revascularization

2010 762 citations Kurt Huber et al. profile →
5-Year Outcomes After Left Atrial Appendage Closure

2017 621 citations Kurt Huber et al. profile →
Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation

2014 614 citations Kurt Huber et al. profile →
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

2019 585 citations Kurt Huber et al. profile →
How to use high-sensitivity cardiac troponins in acute cardiac care

2012 523 citations Christian Mueller, Stefan Blankenberg et al. profile →
Recommendations for the use of cardiac troponin measurement in acute cardiac care

2010 457 citations Marco Tubaro, Christian Mueller et al. profile →
Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation

2013 444 citations Kurt Huber et al. profile →

Peers

Countries citing papers authored by Kurt Huber

Since Specialization

Citations

This map shows the geographic impact of Kurt Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Huber more than expected).

Fields of papers citing papers by Kurt Huber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Huber. The network helps show where Kurt Huber may publish in the future.

Co-authorship network of co-authors of Kurt Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Huber. A scholar is included among the top collaborators of Kurt Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Huber. Kurt Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Experimental Cross Sections for Electron-Impact Single, Double, and Triple Ionization of La+ 2025 ·Atoms ·(unknown), A Borovik, (unknown), Kurt Huber, S. Schippers	0
2	Haemodynamic monitoring and management of the hypotensive out-of-hospital cardiac arrest patient in the adult intensive care unit: a clinical consensus statement of the Association for Acute CardioVascular Care of the ESC 2025 ·European Heart Journal Acute Cardiovascular Care ·Johannes Grand, Alessandro Sionís, Christian Hassager, (unknown), (unknown), Hannah Schaubroeck, (unknown), Konstantin A. Krychtiuk, (unknown), Alexandre Mebazaa, Kurt Huber, Sean van Diepen, (unknown), David A. Morrow, Guido Tavazzi	0
3	Decreased percentages of plasmacytoid dendritic cells predict survival in critically ill patients 2024 ·Journal of Leukocyte Biology ·(unknown), Max Lenz, Konstantin A. Krychtiuk, Christian Hengstenberg, Kurt Huber, Johann Wojta, Gottfried Heinz, Alexander Niessner, Walter S. Speidl, Lorenz Koller	1
4	Presentation, care, coronary intervention and outcomes of patients with NSTEMI according to age: insights from the international prospective ACVC-EAPCI EORP NSTEMI registry 2024 ·Age and Ageing ·Ramesh Nadarajah, Peter Ludman, Cécile Laroche, Yolande Appelman, Salvatore Brugaletta, Andrzej Budaj, Héctor Bueno, Kurt Huber, Vijay Kunadian, (unknown), Maddalena Lettino, Dejan Milašinović, Andrew Clegg, Chris P Gale	2
5	Current spectrum and outcomes of infarct-related cardiogenic shock: insights from the CULPRIT-SHOCK registry and randomized controlled trial 2024 ·European Heart Journal Acute Cardiovascular Care ·Uwe Zeymer, Tobias Heer, Taoufik Ouarrak, (unknown), (unknown), J Stepińska, Keith G. Oldroyd, Pranas Šerpytis, G Montalescot, Kurt Huber, Stephan Windecker, (unknown), Christiaan Vrints, Steffen Schneider, (unknown), Holger Thiele	3
6	Useful aid or futile hassle - continuous rhythm monitoring following acute myocardial infarction 2024 ·EP Europace ·(unknown), (unknown), (unknown), Miklós Rohla, (unknown), Christoph C. Kaufmann, (unknown), Alfred Burger, Anwar Ahmed, Matthias K. Freynhofer, (unknown), (unknown), Kurt Huber, David Zweiker	0
7	Takotsubo Syndrome Before and During the COVID-19 Pandemic in Austria: A Retrospective Cohort Study (TOSCA-19) 2023 ·ESC Heart Failure ·(unknown), David Zweiker, (unknown), (unknown), Ivan Lechner, (unknown), (unknown), Heiko Bugger, Günter Christ, Diana Bonderman, (unknown), Andreas Zirlik, Axel Bauer, Bernhard Metzler, Thomas Lambert, Clemens Steinwender, Kurt Huber	2
8	Balancing Benefits and Risks of Oral Antiplatelet Strategies in patients With Coronary Artery Diseases: An Evolving Issue 2023 ·Current Problems in Cardiology ·Leonardo De Luca, Felice Gragnano, Paolo Calabrò, Kurt Huber	3
9	Pharmacologic modulation of intracellular Na⁺concentration with ranolazine impacts inflammatory response in humans and mice 2022 ·Proceedings of the National Academy of Sciences ·Max Lenz, Manuel Salzmann, Cosmin I. Ciotu, Christoph Kaun, Konstantin A. Krychtiuk, (unknown), Miran Šebeštjen, (unknown), Sabine Rauscher, (unknown), Christoph J. Binder, Kurt Huber, Christian Hengstenberg, Bruno K. Podesser, Michael J. M. Fischer, Johann Wojta, Philipp J. Hohensinner, Walter S. Speidl	5
10	Heart failure 2019. Insights from the National Society of Cardiology Journals 2021 ·REC CardioClinics ·Plamen Gatzov, Jean-Jacques Monsuez, Gergely Ágoston, Michael Aschermann, Hala Mahfouz Badran, Ariel Cohen, Kurt Huber, Е. V. Shlyakhto, Dilek Ural, Ignacio Ferreira‐González, Fernándo Alfonso	1
11	Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression 2021 ·Biomedicines ·Max Lenz, Christoph Kaun, Konstantin A. Krychtiuk, (unknown), (unknown), (unknown), (unknown), Christoph J. Binder, Kurt Huber, Christian Hengstenberg, Johann Wojta, Philipp J. Hohensinner, Walter S. Speidl	18
12	Impact of Center Volume on Outcomes in Myocardial Infarction Complicated by Cardiogenic Shock: A CULPRIT‐SHOCK Substudy 2021 ·Journal of the American Heart Association ·Benedikt Schrage, Uwe Zeymer, Gilles Montalescot, Stephan Windecker, Pranas Šerpytis, Christiaan Vrints, Janina Stępińska, Stefano Savonitto, Keith G. Oldroyd, Steffen Desch, Georg Fuernau, Kurt Huber, Marko Noč, Steffen Schneider, Taoufik Ouarrak, Stefan Blankenberg, Hölger Thiele, Peter Clemmensen	3
13	ApPropRiateness - Stanetic of myOcardial revascUlarization assessed by SYNTAX Scores in patients with type 2 diabetes melliTus: the PROUST study* 2020 ·Advances in Interventional Cardiology ·Bojan Stanetić, Miodrag Ostojić, Tamara Kovačević-Preradović, (unknown), (unknown), Aleksandra Nikolić, Milovan Bojić, Kurt Huber	1
14	Impact of platelet turnover on long‐term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention 2019 ·European Journal of Clinical Investigation ·Maximilian Tscharre, Serdar Farhan, (unknown), Miklós Rohla, (unknown), Thomas W. Weiss, Wolfgang Hübl, Martin Willheim, Johann Wojta, Alexander Geppert, Kurt Huber, Matthias K. Freynhofer	22
15	Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 2019 ·The American Journal of Medicine ·Giuseppe Patti, Ladislav Pecen, Markus Lucerna, Kurt Huber, Miklós Rohla, Giulia Renda, Jolanta M. Siller‐Matula, Fabrizio Ricci, Paulus Kirchhof, Raffaele De Caterina	41
16	Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 2018 ·International Journal of Cardiology ·Giuseppe Patti, Ladislav Pecen, Markus Lucerna, Kurt Huber, Miklós Rohla, Giulia Renda, Jolanta M. Siller‐Matula, Renate B. Schnabel, Roberto Cemin, Paulus Kirchhof, Raffaele De Caterina	18
17	Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 2018 ·International Journal of Cardiology ·Jolanta M. Siller‐Matula, Ladislav Pecen, Giuseppe Patti, Markus Lucerna, Paulus Kirchhof, Maciej Lesiak, Kurt Huber, Freek W.A. Verheugt, Iréne Lang, Giulia Renda, Renate B. Schnabel, Rolf Wachter, Dipak Kotecha, Jean‐Marc Sellal, Miklós Rohla, Fabrizio Ricci, Raffaele De Caterina	30
18	Gestione pre-ospedaliera dei pazienti con dolore toracico e/o dispnea di origine cardiaca. <BR>Position Paper Acute Cardiovascular Care Association (ACCA) della Società Europea di Cardiologia 2017 ·Recenti Progressi in Medicina ·Farzin Beygui, Maaret Castrén, Natale Daniele Brunetti, Fernando Rosell Ortiz, Michael Christ, Uwe Zeymer, Kurt Huber, Fredrik Folke, Leif Svensson, Héctor Bueno, Arnoud W.J. van ‘t Hof, Νικόλαος Νικολάου, Lutz Nibbe, Sandrine Charpentier, Eva Swahn, Marco Tubaro, Patrick Goldstein	1
19	Copeptin for the early rule-out of non-ST-elevation myocardial infarction 2016 ·International Journal of Cardiology ·(unknown), (unknown), Christian Mueller, Johann Wojta, Kurt Huber	22
20	Complementary Role of Copeptin and High-Sensitivity Troponin in Predicting Outcome in Patients with Stable Chronic Heart Failure 2011 ·European Journal of Heart Failure ·Ioannis Tentzeris, Rudolf Járai, Serdar Farhan, Thomas Perkmann, Michael Schwarz, Gabriele Jakl, Johann Wojta, Kurt Huber	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact